VLTO Stock Analysis: Veralto | NYSE
Pollution & Treatment Controls | NYSE, USA | Market Cap: 23.514m USD | 12M Return: -5.2% | US92338C1036 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 163M
Qual. Beats: 4
Rev. Trend: 98.8%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Veralto Corporation (NYSE: VLTO) is an industrial technology company that provides water analytics, water treatment, marking and coding, and packaging and color solutions to customers worldwide. The company operates through two reportable segments: Water Quality (WQ) and Product Quality & Innovation (PQI), serving end markets such as municipal utilities, food and beverage, pharmaceutical, and industrial customers.
The WQ segment supplies precision instrumentation, water treatment technologies, chemical reagents, services, and software for residential, commercial, municipal, industrial, research, and natural resource applications under brands such as Hach, Trojan Technologies, and ChemTreat. The PQI segment delivers marking and coding systems, digital asset and product information management software, inline printing solutions, packaging design software, and color management solutions under the Videojet, Linx, Esko, X-Rite, and Pantone brands. Many of these offerings (such as the Pantone color standards and Hach water analysis instruments) are recognized category leaders, reflecting a business model built on mission-critical, recurring or specification-driven demand rather than purely discretionary spending.
Veralto was incorporated in 2022 and is headquartered in Waltham, Massachusetts. The company was formerly known as DH EAS Holding Corp. and was spun off from Danaher Corporation, beginning trading on the NYSE on October 4, 2023, under its current name, which it adopted in February 2023. The company is classified within the GICS Industrials sector, specifically the Environmental & Facilities Services sub-industry, a categorization that reflects the central role of regulatory-driven water quality and environmental compliance in its revenue base.
- PFAS and lead regulations boost municipal water treatment demand
- Infrastructure bill funding expands municipal utility segment revenue
- Esko and X-Rite software margins lift consolidated profitability
| Net Income: 988.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.92 > 1.0 |
| NWC/Revenue: 28.00% < 20% (prev 31.29%; Δ -3.29% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.10b > Net Income 988.0m |
| Net Debt (1.47b) to EBITDA (1.39b): 1.05 < 3 |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (245.8m) vs 12m ago -1.64% < -2% |
| Gross Margin: 60.18% > 18% (prev 59.88%; Δ 0.30% > 0.5%) |
| Asset Turnover: 72.43% > 50% (prev 74.77%; Δ -2.35% > 0%) |
| Interest Coverage Ratio: 14.14 > 6 (EBIT TTM 1.30b / Interest Expense TTM 92.0m) |
| A: 0.19 (Total Current Assets 3.65b - Total Current Liabilities 2.06b) / Total Assets 8.56b |
| B: 0.25 (Retained Earnings 2.17b / Total Assets 8.56b) |
| C: 0.17 (EBIT TTM 1.30b / Avg Total Assets 7.86b) |
| D: 0.57 (Book Value of Equity 3.10b / Total Liabilities 5.46b) |
| Altman-Z'' = 3.76 = AA |
| DSRI: 0.99 (Receivables 921.0m/878.0m, Revenue 5.70b/5.36b) |
| GMI: 1.00 (GM 59.88% / 60.18%) |
| AQI: 0.98 (AQ_t 0.54 / AQ_t-1 0.55) |
| SGI: 1.06 (Revenue 5.70b / 5.36b) |
| TATA: -0.01 (NI 988.0m - CFO 1.10b) / TA 8.56b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of October 12, 2026, the stock is trading at USD 96.93 with a total of 890,671 shares traded. Over the past week, the price has changed by +2.38%, over one month by +2.47%, over three months by +5.39% and over the past year by -5.24%.
Current recommended Stop Loss: 94.50 (which is 2.5% or 1.3 ATR below the current price).
Veralto has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy VLTO.
- StrongBuy: 8
- Buy: 2
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 114.2 | 17.8% |
P/E Trailing = 24.2947
P/E Forward = 19.9601
P/S = 4.1281
P/B = 7.5476
P/EG = 2.2699
Revenue TTM = 5.70b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 2.68b USD (from longTermDebt, last quarter)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 3.58b USD (from shortLongTermDebtTotal, last quarter) + Leases 206.0m
Net Debt = 1.47b USD (calculated: Debt 3.58b - CCE 2.12b)
Enterprise Value = 25.0b USD (23.5b + Debt 3.58b - CCE 2.12b)
Interest Coverage Ratio = 14.14 (Ebit TTM 1.30b / Interest Expense TTM 92.0m)
EV/FCF = 23.86x (Enterprise Value 25.0b / FCF TTM 1.05b)
FCF Yield = 4.19% (FCF TTM 1.05b / Enterprise Value 25.0b)
FCF Margin = 18.38% (FCF TTM 1.05b / Revenue TTM 5.70b)
Net Margin = 17.35% (Net Income TTM 988.0m / Revenue TTM 5.70b)
Gross Margin = 60.18% ((Revenue TTM 5.70b - Cost of Revenue TTM 2.27b) / Revenue TTM)
Gross Margin QoQ = 61.19% (prev 60.06%)
Tobins Q-Ratio = 2.92 (Enterprise Value 25.0b / Total Assets 8.56b)
Interest Expense / Debt = 2.57% (Interest Expense 92.0m / Debt 3.58b)
Taxrate = 18.28% (221.0m / 1.21b)
NOPAT = 1.06b (EBIT 1.30b * (1 - 18.28%))
Current Ratio = 1.78 (Total Current Assets 3.65b / Total Current Liabilities 2.06b)
Debt / Equity = 1.16 (Debt 3.58b / totalStockholderEquity, last quarter 3.10b)
Debt / EBITDA = 1.05 (Net Debt 1.47b / EBITDA 1.39b)
Debt / FCF = 1.40 (Net Debt 1.47b / FCF TTM 1.05b)
Total Stockholder Equity = 3.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.56% (Net Income 988.0m / Total Assets 8.56b)
RoE = 32.79% (Net Income TTM 988.0m / Total Stockholder Equity 3.01b)
RoCE = 22.85% (EBIT 1.30b / Capital Employed (Equity 3.01b + L.T.Debt 2.68b))
RoIC = 15.37% (NOPAT 1.06b / Invested Capital 6.92b)
WACC = 6.59% (E(23.5b)/V(27.1b) * Re(7.27%) + D(3.58b)/V(27.1b) * Rd(2.57%) * (1-Tc(0.18)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -31.87 | Cagr: -0.54%
[DCF] Terminal Value 76.78% ; FCFF base≈1.01b ; Y1≈1.10b ; Y5≈1.39b
[DCF] Fair Price = 81.07 (EV 21.2b - Net Debt 1.47b = Equity 19.8b / Shares 243.8m; r=8.35% [WACC [floored]]; 5y FCF grow 11.03% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 4.0 | # QB: 4
Revenue Correlation: 98.81 | Revenue CAGR: 5.08% | SUE: 1.00 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.09 | Chg30d=+0.19% | Revisions=+46% | Analysts=12
EPS current Year (2026-12-31): EPS=4.40 | Chg30d=+0.02% | Revisions=+85% | GrowthEPS=+12.9% | GrowthRev=+7.4%
EPS next Year (2027-12-31): EPS=4.79 | Chg30d=+0.31% | Revisions=+75% | GrowthEPS=+8.8% | GrowthRev=+5.8%
[Analyst] Revisions Ratio: +81% (up=41, down=3)